Stocktoria
Design Therapeutics, Inc. DSGN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Design Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 2,366,453 | $34.2M | 3.92% |
| BlackRock Finance, Inc. | 2,304,948 | $7.7M | 3.82% |
| RENAISSANCE TECHNOLOGIES LLC | 387,913 | $5.6M | 0.64% |
| D. E. Shaw & Co., Inc. | 195,645 | $2.8M | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 147,714 | $2.1M | 0.24% |
| CITADEL ADVISORS LLC | 95,871 | $1.4M | 0.16% |
| AQR CAPITAL MANAGEMENT LLC | 71,114 | $1.0M | 0.12% |
| TWO SIGMA INVESTMENTS, LP | 32,925 | $476,425 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.